tafamidis Articles

US FDA calls for more efficacy data on Pfizer's tafamidis NDA

19 June 2012

FDA advisory panel gives mixed views on Pfizer's tafamidis

25 May 2012

FDA expands Levemir use to young children; negative on tafamidis

23 May 2012

FDA now accepts Pfizer’s tafamidis NDA

16 February 2012

Pfizer’s Vyndaqel, first drug to treat rare and fatal disease TTR-FAP, approved in Europe

18 November 2011

Pfizer to sell Capsugel unit to KKR for $2.38 billion; FDA turns down tafamidis filing

5 April 2011

Pfizer to buy privately-held drug discovery firm FoldRx to expand rare diseases portfolio

2 September 2010

Showing 1-7 of 7 articles

Go to beginningPrevious
  • 1
NextGo to end